Introduction
============

Congenital cardiac malformations are the most common life-threatening birth defects [@B1]. Most major malformations are detected at birth, but less severe defects can go undetected, leading to cardiac disease later in life [@B2]. In mice, the development of the heart begins with the formation of the cardiac tube, which soon undergoes dextral looping and other morphogenic events to form the heart chambers [@B3]. During this process, the ventricles and atria become partially separated by the formation of atrioventricular cushions. The valves and septa arise from these cushions, through inductive influences from the underlying myocardium [@B4]-[@B6].

Transforming growth factor β (TGFβ) and bone morphogenic protein (BMP) ligands and/or their receptors are expressed by myocardium, endocardium, cushion mesenchyme, epicardium, cardiac neural crest cells and second heart field cardiac progenitor cells [@B7]-[@B9]. Mice with gene targeted mutation in TGFβ or BMP pathways exhibit multiple cardiovascular developmental defects, including valvuloseptal septal defects [@B10]-[@B20]. These malformations are consistent with myocardial TGFβ2 and BMP2/4 acting on the overlying cushion to promote an epithelial to mesenchymal transition of a distinct group of endocardial cells [@B21],[@B22].

The TGFβs and BMPs are members of the TGFβ superfamily of proteins, which signal through a complex consisting of type I and II receptors. Signal transduction is mainly through the SMAD pathway [@B23], although other pathways such as PI3K-Akt and Ras-Raf have been implicated in some physiological events [@B24]. There are 8 SMADs, which can be sub-divided into three functional groups. The receptor-mediated SMADs (SMAD1, 2, 3, 5, 8) are directly phosphorylated by the TGFβ receptors, and then translocated to the nucleus, after binding to the single co-mediator SMAD, SMAD4 [@B24]. The inhibitory SMADs (SMAD6, 7) reduce signaling by preventing activation of the receptor mediated-SMADs [@B23]. SMAD6 appears to be specific for BMP signaling, whereas SMAD7 can reduce either BMP or TGFβ based signaling pathways [@B25]-[@B27].

The role of the single co-mediator SMAD, *Smad4,* in the myocardium is unclear due to variations in the timing and efficiency of previous myocardial-specific deletions of *Smad4* [@B28]-[@B30]. *Smad4* deficient embryos die shortly after implantation [@B31], but the broad actions of SMAD4 can be investigated through cell-specific deletions [@B32]-[@B35]. We report here that a broad myocardial conditional deletion of *Smad4* produces a double-outlet right ventricle (DORV), as well as other cardiac malformations. This suggests that myocardial-SMAD4 has a more extensive role in cardiac morphogenesis than currently reported. The novel alpha skeletal muscle actin Cre transgenic mouse (*MuCre*) used in this study produces early, rapid and robust cleavage of floxed genes, making it a valuable tool for the study of both cardiac and skeletal muscle formation.

Materials and Methods
=====================

Animals
-------

The University of Otago\'s Animal Ethics Committee approved all experiments. Mice were bred and maintained in M.I.C.E.™ cages and their food sterilized by gamma irradiation. The room had a 14h white light / 10h dark-sodium light phase [@B35]. Floxed-*Smad4*(*Smad4*^flox/flox^) [@B36] and ROSA26^LacZ^[@B37] mice were bred at the University of Otago.

Generation of MuCre mice
------------------------

The *MuCre* mice carried a transgene consisting of a human alpha skeletal muscle actin promoter [@B38] and the bacteriophage P1 Cre recombinase gene [@B39]. The DNA fragments containing the α-skeletal muscle actin promoter and the Cre recombinase gene were isolated from the original clones, integrated into a new cloning vector using standard techniques. The construct was verified by nucleotide sequencing. The transcription unit was then isolated by cleavage of the clone with restriction endonucleases, preparative agarose gel electrophoresis and a DNA isolation kit (QIAGEN). It was then injected into C57BL/6 zygotes (TASQ, University of Queensland, St Lucia, Australia) and the *MuCre* line was selected from 14 founders, as it had the highest level of Cre recombinase expression. Two different Cre transgenic lines (MuCreA and MuCreB) were generated and characterised. These lines were maintained by breeding transgenic mice with C57BL/6 mice. *MuCre* refers to the A line, unless otherwise stated. The mice are available from the Riken Bioresource Centre (\#RBRC01386, *MuCre-A*).

The genotype of the mice was determined from ear biopsies, using polymerase chain reaction (PCR), as previously described [@B40]. The primers used were: Floxed *Smad4*, 5\'-GGGCAGCGTAGCATATAAGA-3\' and 5\'-TGACCCAAACGTCACCTTCA-3\'; ROSA26^LacZ^, 5\'-GTTGCAGTGCACGGCAGATACACTTGCTGA-3\' and 5\'-GCCACTGGTGTGGGCCATAATTCAATTCGC-3\'; *MuCre*, 5\'-GTTGATGCCGGTGAACGTGCAAA-3\' and 5\'-ATCAGCTACACCAGAGACGGAAA-3\'.

The tissue-specificity of Cre expression was examined by quantitative (q) PCR. Total RNA was extracted from the brain, spinal cord, kidney, liver, gastrocnemius muscle and heart using TRIzol reagent, according to the manufacturer\'s instructions (Invitrogen, Carlsbad, Ca, USA). The total RNA fractions of each sample were DNase treated to remove possible contamination of genomic DNA and then reverse transcribed using SuperScript II Rnase H^-^ reverse transcriptase (Invitrogen) and oligo d(T)~15~ as primer. Cre cDNA were amplified using primers CreER-F2 (5\'-GTT GAT GCC GGT GAA CGT GCA AA-3\') and CreER-R1 (5\'-ATC AGC TAC ACC AGA GAC GGA AA-3\'). GAPDH cDNA were co-amplified using primers GAPDH-forward (5\'-CTT CAT TGA CCT CAA CTA-3\') and GAPDH-reverse (5\'-TTC ACA CCC ATC ACA AAC-3\') and used as internal control. Real-time PCR were performed using SYBR Green 1 dye (Invitrogen). Measurements were realized and analyzed by using the ABI Prism 7700 sequence detection system (Applied Biosystems, Foster City, CA, USA).

The characteristics of the *MuCre* mice were also verified by breeding them with LacZ/alkaline phosphatase (Z-AP) double reporter and ROSA26^LacZ^ reporter mice [@B37], [@B41]. In the Z-AP mice, the action of Cre recombinase terminates the production of LacZ and induces alkaline phosphatase (AP) [@B41]. Successful cleavage is thus indicated by both the loss of LacZ stain and the induction of AP expression.

Embryos were produced at E11.5, E14.5 and E16.5 from time-mated pregnancies, with the date of the vaginal plug designated as E0.5. A proportion of these were stained *in situ* for LacZ. The dams were killed, the embryos removed and fixed in a solution containing 0.2% glutaraldehyde, 5mM EGTA, 2mM MgCl~2~ in phosphate-buffered saline (PBS) for 10 minutes at 4°C. The embryos were washed three times in PBS containing 2mM MgCl~2~ and 1% NP40, and incubated in a solution containing 2.45mM X-Gal, 2mM MgCl~2~, 20mM K~3~Fe(CN)~6~, 20mM K~4~Fe(CN)~6~ in PBS for 3 hours. After washing three times in PBS, the embryos were fixed again overnight at 4°C, embedded in Technovit 7100 resin and serially-sectioned at 15µm.

Tissues from embryos and adults were snap frozen in melting isopentane, and sectioned using a cryostat. LacZ staining of the section was as previously described [@B42]. For alkaline phosphatase (AP) staining, the sections were fixed with 2% paraformaldehyde in 0.1M sodium phosphate buffer, pH 7.4, washed in AP buffer (100mM Tris-HCl pH 9.5, 100mM NaCl and 5mM MgCl~2~) for 2 minutes and incubated in 318µg/ml nitroblue tetrazolium, 108µg/ml 5-bromo-4-chloro-3-indolyl phosphate, para-toluidium salt and 102µg/ml levamisole in AP buffer for 10 minutes.

The Cre recombinase-ERT contains a tamoxifen-sensitive estrogen receptor domain, which is designed to hold the Cre recombinase in the cytoplasm of the cell, unless tamoxifen is present [@B39]. This enables temporal control of the cleavage of target sequences, but this strategy is only effective in some mouse lines [@B43]. The *MuCre* mice rapidly cleaved target sequences in the absence of tamoxifen, indicating that the Cre recombinase enters the nucleus independent of tamoxifen. The data presented here are therefore from mice that did not receive tamoxifen.

Assessment of cardiac malformations
-----------------------------------

The embryos produced by crossing *MuCre/Smad4*^flox/+^ and *Smad4*^flox/flox^mice were fixed in 4% paraformaldehyde in 0.1M phosphate buffer, pH7.4. The hearts from five *MuCre/Smad4*^flox/flox^ and six control mice were embedded in wax, serially sectioned at 5µm and stained with hematoxylin and eosin for the histological and morphometric examination.

Results
=======

MuCre mice have cardiac and skeletal muscle expression of Cre recombinase
-------------------------------------------------------------------------

Muscle-specific Cre recombinase transgenic mouse lines (*MuCre*) were generated using an α skeletal muscle actin promoter. The endogenous α-skeletal muscle actin promoter is skeletal-muscle specific, but when used in transgenic mice it drives expression in the heart, in a minority of mouse lines [@B38]. Consistent with this, the hearts of adult *MuCre* mice had levels of Cre recombinase mRNA that varied from 0.1% (line B) to 40% (line A, MuCrA, hereafter referred to as *MuCre*) of the level in skeletal muscle. Cre recombinase mRNA was not detected in the brain, spinal cord, liver or kidneys of the *MuCre* mice. The *MuCre*mice alone did not exhibit a phenotype.

The cells expressing the Cre recombinase were examined by crossing the *MuCre* mice with a ROSA26^LacZ^ and/or the Z-AP reporter mice, with the observed pattern of stain being consistent with the mRNA data. In whole mount E11.5 *MuCre/ROSA26^LacZ^*embryos, the LacZ reporter staining was detected in the developing heart and skeletal muscles (Fig. [1](#F1){ref-type="fig"}A). Sectioning of the heart revealed strong staining in the myocardium of atria, ventricles and outflow tract (outflow tract) and atrioventricular (AV) canal myocardium, but not in the endocardial cushions (Fig. [1](#F1){ref-type="fig"}B). Skeletal myotubes were also stained (red arrows in Fig. [1](#F1){ref-type="fig"}B).

The tissue-specific expression of the *MuCre* mice was then examined using cryostat sections of *MuCre/Z-AP* mice, with Cre recombinase expression being detected by the induction of alkaline phosphatase (AP) and the cessation of LacZ expression. In control non-transgenic Z-AP mice all cells were LacZ positive and AP negative (compare Fig [2](#F2){ref-type="fig"}A with 2D). By contrast, the skeletal muscles of the *MuCre/Z-AP* mice, the muscle fibers were LacZ negative (Fig. [2](#F2){ref-type="fig"}B) and AP positive (Fig. [2](#F2){ref-type="fig"}E), indicating that all muscle fibers had produced high levels of Cre recombinase. The interstitial cells of the muscles, including neural crest-derived Schwann cells (arrow in Fig. [2](#F2){ref-type="fig"}B) were LacZ positive. The expression of AP was limited to a small population of resident macrophages that naturally produce AP (arrows in Fig. [2](#F2){ref-type="fig"}D). The complete removal of LacZ and the induction of AP were also observed in all myotubes (immature muscle fibers) of E14.5, E16.5 and newborn *MuCre/Z-AP* mice (compare Fig. [2](#F2){ref-type="fig"}C with 2F). The myoblasts and other mononucleated cells were negative for AP (arrows in Fig. [2](#F2){ref-type="fig"}G). This indicates that the cleavage of target DNA in the myotubes was very rapid, as many of these immature muscle fibers were only a few hours old. All cardiac myocytes of the adult *MuCre/Z-AP* mice were AP negative (Fig. [3](#F3){ref-type="fig"}D) and LacZ positive (Fig. [3](#F3){ref-type="fig"}B). By contrast, no cleavage of the reporter construct was observed in control hearts, with the myocytes being LacZ negative (Fig. [3](#F3){ref-type="fig"}A). No cleavage of the reporter gene was observed in other tissues, including the brain, spinal cord, liver and intestines. In summary, the *MuCre* mouse line specifically express Cre recombinase in cardiac and skeletal muscles. The level of expression of the Cre recombinase in both these muscle types is high leading to extremely rapid and robust cleavage of target sequences.

Muscle-specific deletion of Smad4 leads to mid-gestational lethality
--------------------------------------------------------------------

*MuCre*/*Smad4*^+/flox^ mice were crossed with *Smad4*^flox/flox^ mice to produce*MuCre*/*Smad4*^flox/flox^ (hereafter referred to as myocardial *Smad4* conditional knockout) mice. Sixty 10-day-old pups were produced from 14 litters. The data indicated that myocardial *Smad4* conditional knockout died *in utero*(Table [1](#T1){ref-type="table"}). The fetuses from 19 time-mated litters were therefore collected. Myocardial *Smad4* conditional knockout fetuses were present at the Mendelian ratio (32/125, Table [1](#T1){ref-type="table"}), but most of the conditional knockout fetuses older than 13-14 days of gestation were dead *in utero* (Table [1](#T1){ref-type="table"}). The death of the myocardial *Smad4* conditional knockout fetuses was independent of whether the *MuCre*transgene was carried by the dam or by the stud.

Loss of Smad4 in myocardium causes defects in cardiac morphogenesis
-------------------------------------------------------------------

Histological examination by hematoxylin and eosin (H&E) staining was done on serial sections of E11.5-13.5 fetuses of myocardial *Smad4* conditional knockout (*n* = 7) and the littermate *MuCre* non-transgenic *Smad4*^flox/flox^ control embryos (*n* = 5) to determine why the fetuses with myocardial *Smad4* deletion die. At E11.5, the transgene was strongly expressed (Fig. [1](#F1){ref-type="fig"}), but all of the fetuses were still viable (Table [1](#T1){ref-type="table"}). The control fetuses had a normal cardiac outflow tract and AV septation and alignment, compact ventricular myocardium, and the endocardial cushions (Fig. [4](#F4){ref-type="fig"}A,C,E,G). By contrast, myocardial *Smad4* conditional knockout fetuses exhibited cardiac defects, including double-outlet right ventricle (DORV) (Fig. [4](#F4){ref-type="fig"}D,H), ventricular septal defect (VSD) (Fig. [4](#F4){ref-type="fig"}D,H), decreased density of trabeculae in the ventricles and thinning of the compact layer of the ventricular myocardium (Fig. [4](#F4){ref-type="fig"}B,D,H,F). DORV was seen with the aortic orifice being in a side-by-side position to the pulmonary orifice (Fig. [4](#F4){ref-type="fig"}B). In control embryos, tissue between aortic valve and right ventricular outflow tract became myocardial structure (Fig. [4](#F4){ref-type="fig"}C). By contrast, only a small fibrous ridge separated the aortic valve from the right ventricular outflow tract in myocardial *Smad4* conditional knockout fetuses (Fig. [4](#F4){ref-type="fig"}D). This can be attributed to the fact that the outlet cushions are proximally not fused in the conditional knockout embryos (Fig. [4](#F4){ref-type="fig"}D). The cardiac phenotype was the same in all embryos examined, indicating that the penetrance of the genetic modification is very high.

In the control E13.5 embryos, the fusion of mesenchyme at the base of the atrial septum and AV cushions nearly completed the inlet septation. However, in the myocardial *Smad4* conditional knockout embryos, there was a large perimembranous inlet ventricular septal defect (VSD) due to absence of mesenchyme in the region where outflow tract and the AV cushions should have met (Fig. [4](#F4){ref-type="fig"}H). The VSD was more closely related to the aortic orifice in the conditional knockout embryo (Fig. [4](#F4){ref-type="fig"}D). It is also noteworthy that the bifurcated outflow tract is in the right ventricle and not over the ventricular septum (Fig. [4](#F4){ref-type="fig"}D). The size and the cellularity of endocardial cushions were normal, but their appearance was slightly abnormal (Fig. [4](#F4){ref-type="fig"}H), which we attributed to the impaired cardiac alignment process in the conditional mutants.

Discussion
==========

This study provides clear evidence that muscle-specific deletion of *Smad4* leads to defective alignment but not septation of the aortic and pulmonary orifices, resulting in DORV. Interestingly, cardiac phenotypes of myocardial *Smad4* conditional knockout mice shares many similarities to the cardiac phenotypes observed in *Tgfb2*^-/-^, and TGFβ receptors and *Bmp2*,*Bmp4*and BMP receptors conditional knockout mice [@B10],[@B12]-[@B20],[@B45]. Both TGFβ and BMP ligands play important roles in cardiac morphogenesis by properly recruiting second-heart field progenitors to the outflow tract and to the ventricular myocardium to the developing heart [@B45],[@B46]. The data suggest a unique requirement of myocardium-produced SMAD4 in the outflow tract alignment since endothelial or cardiac neural crest cell-specific deletion of *Smad4* leads to defects in cushion formation or outflow tract septation but not in misalignment of the outflow tract [@B47],[@B48].

The cardiac phenotype of the *MuCre*/*Smad4*^flox/flox^ mice is more extensive than previous studies of myocyte-specific deletion of *Smad4*, which have used different promoters to drive the Cre recombinase [@B28]-[@B30]. The *Smad4*^flox/flox^ mice used in these studies are from a common lineage [@B36], suggesting that the difference in the phenotype relates to the characteristics of the promoters. Alternatively, the phenotypes of mice with TGFβs mutations are influenced by their genetic background [@B49]-[@B51] and by environmental factors [@B52], and SMAD4 biology could thus be subject to similar regulation.

The development of the heart can proceed normally with attenuated growth factor signaling, as evidenced by the normality of *MuCre*/*Smad4^flox/+^*mice (this study) and mice with single gene haploinsufficiency for *Tgfb2*, *Bmp2* or *Bmp4* [@B10],[@B12],[@B13],[@B53]. The success of conditional genetic manipulation is thus dependent on early and rapid removal of both alleles of the target gene. Similarly, it may be important for a high percentage of cells to be affected, as a minority of normal cells may be sufficient to drive some morphogenetic events. The *MuCre* mice effectively achieve these criteria, as evidenced by the speed and completion of removal of floxed genes in the ROSA26^LacZ^ and Z-AP reporter mice, and by the severity of the phenotype of *MuCre*/*Smad4*^flox/flox^ mice.

The cardiac malformations in *MuCre*/*Smad4*^flox/flox^ mice are concordant with other recent studies of myocyte-specific deletion of *Smad4*, which have used *αSMACre* and *cTntCre* mice [@B29],[@B30], except for DORV, which is unique to the *MuCre*/*Smad4*^flox/flox^mice. The inductive events that underlie DORV precede those that underlie the other malformations, and presence of DORV in the *MuCre*/*Smad4*^flox/flox^ may be because the *MuCre* mice drive early and possibly more robust removal of floxed genes as compared to the α*SMACre* driver mouse lines. Although *cTnt-Cre* mice were effective in robustly deleting *Smad4* in early myocardial progenitors at E7.5, it was not possible to determine DORV in *cTnt-Cre*/*Smad4*^flox/flox^ mice due to their death before E12.5. Many studies suggested that an interaction between cardiac neural crest cells and second-heart field-derived myocardium play an important role in outflow tract septation and alignment [@B45]. Since the current study shows that outflow tract is correctly septated but improperly aligned, it is possible that a defective interaction between cardiac neural crest and second-heart field-derived outflow tract myocardium is involved in the formation of DORV in myocardial *Smad4* conditional knockout embryos.

Alpha-myosin heavy chain *αMHCCre*/*Smad4*^flox/flox^mice exhibit normal heart development, which is in marked contrast to the *MuCre*, *αSMACre, cTntCre*equivalents. *αMHCCre* mice are commonly used to study cardiac biology, and have proven utility for the study of adult function [@B41],[@B54]. Their use for the study of cardiac development has yielded conflicting results and the expression of Cre in *αMHCCre* mice may be insufficiently strong or not early to affect all aspects of myocardial development [@B28],[@B30],[@B55]. While it is difficult to draw any parallel between *MuCre* and *αMHCCre* expression, it is clear that *MuCre* mice effectively delete genes in myocardium during early cardiac development and in the adulthood.

The *MuCre* mice were initially developed to study skeletal muscle formation, and they provide rapid and complete removal of floxed genes from myotubes. The *MuCre* mice may therefore be useful for the study of skeletal myogenesis, provided the target gene is not expressed in the heart. The dual skeletal and cardiac effects of *MuCre* mice are less problematical for the study of the heart, as embryos develop to term in the complete absence of skeletal muscle [@B44].

In summary, we report the generation of a new line of α-skeletal-actin Cre-recombinase transgenic mice, which should facilitate the study of cardiac and skeletal myogenesis. The value of these mice is evidenced by their use to provide new insight into the role of *Smad4* in outflow tract morphogenesis processes during heart development.
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![***MuCre*-driven expression of ROSA26^LacZ^ reporter gene in developing skeletal and cardiac muscle cells.** A: Whole mount LacZ staining in E11.5 *MuCre*/*ROSA26^LacZ^* and a littermate non-transgenic control fetuses. The white arrow points to LacZ stain in the heart. B: The *MuCre/ROSA26^LacZ^* fetuses were stained for LacZ, embedded in Technovit resin and serially sectioned. The LacZ stain was present in cardiac myocytes (black arrow) and skeletal muscle myotubes (red arrowheads) of the developing limb (L). EC, endocardial cushion; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle. The scale bar represents 500 µm.](ijbsv06p0546g01){#F1}

![***MuCre-*driven expression of the Z-AP reporter genes in skeletal muscle myotubes and fibers.** With the Z-AP reporter, Cre activity is detected by the expression of alkaline phosphatase (AP) and the cessation of LacZ expression. A, D: Sections of skeletal muscle from an adult non-transgenic Z-AP reporter mouse. All muscle fibres were LacZ-positive and AP-negative (A and D respectively). The expression of AP was restricted to resident macrophages (arrows in D). B, C, E, F, G: Sections of skeletal muscle from adult (B, E), neonatal (C, F) or E16.5 (G) *MuCre/Z-AP*mice. Activation of Cre was limited to the myogenic cells, which were AP-positive (E, F and G) and LacZ-negative (B and C). The non-myogenic cells in the muscle lack Cre expression. For example, the arrow in (B) points to an intramuscular nerve, whereas the arrowheads in (C, F) point to an intramuscular tendon, which had minimal expression of reporter genes. The AP-positive myotubes in (G) are indicated by an arrowhead, whereas the AP-negative mononucleated cells are indicated by arrows. It is also noteworthy that the AP staining of muscle fibers in (E) is specific because AP staining is absent in the negative control (D). The scale bar = 50µm (A-F) and 30 µm (G).](ijbsv06p0546g02){#F2}

![***MuCre-*driven expression of the Z-AP reporter genes in adult cardiac myocytes.** With the Z-AP reporter, Cre activity is detected by the expression of alkaline phosphatase (AP) and the cessation of LacZ expression. A,C: The hearts from control non-transgenic Z-AP reporter mice were LacZ negative and had high levels of AP. B,D: All myocytes in the hearts of *MuCre/Z-AP*mice were LacZ positive (B) and only had low endogenous AP expression (D). The black (A, B) and the white arrows in (C,D) point to myocytes. V, ventricle. The bar represents 500 µm.](ijbsv06p0546g03){#F3}

![**SMAD4 is essential for cardiac morphogenesis.** A-F: Light micrographs of serial sections of E13.5 non-transgenic control (A, C, G, E) or *MuCre*/*Smad4*^flox/flox^(B, D, H, F) fetuses stained with haematoxylin and eosin. Asterisk (\*) in B shows an abnormal side-by-side alignment of aorta (ao) and pulmonary trunk (pt) leading to the DORV. (D) Asterisk (\*) in D indicates missing right ventricular outflow tract septum and a fully developed double-outlet right ventricle (DORV) in the myocardial *Smad4* conditional knockout embryo. A clear ventricular septal defect is seen in D (double asterisks) H (asterisk) in the myocardial *Smad4* conditional knockout embryo. Note that the DORV is positioned in the right ventricle and not over the ventricular septum (double asterisk in D). Impaired myocardial trabeculation and myocardial hypoplasia in the interventricular septum (arrow in D and H), and thinning of the compact layer of the ventricular myocardial walls (D, H, F) (arrowhead in D & H) is found in the myocardial *Smad4* conditional knockout. E-F are 100% zoomed or enlarged images of the boxed regions in G & H, respectively. pv, pulmonary valves; rv, right ventricle; lv, left ventricle; ra, right atrium; la, left atrium; ivs, interventricular septum; mv, mitral valves; tv, tricuspid valves. The scale bars = 200 µm (A-H).](ijbsv06p0546g04){#F4}

###### 

Significant mid-gestational embryonic lethality in myocardial *Smad4* conditional knockout mice.

  Genotypes                      E12.5-13.5   E14.5              E18.5              P10
  ------------------------------ ------------ ------------------ ------------------ ----------
  *Smad4*^flox/+^ (control)      6 (14%)      12 (35%)           12 (24%)           18 (30%)
  *Smad4*^flox/flox^ (control)   13 (30%)     8 (24%)            14 (28%)           16 (27%)
  *MuCre*/*Smad4*^flox/+^        10 (23%)     6 (18%)            12 (24%)           26 (43%)
  *MuCre*/*Smad4*^flox/flox^     14 (33%)     2 \[6\] (6, 18%)   2 \[8\] (4, 16%)   0 (0%)
  Number of fetuses/mice         43           34                 50                 60
  Number of litter               5            5                  6                  10

*MuCre*/*Smad4*^flox/+^ and non-transgenic *Smad4*^flox/flox^ mice were mated and their offspring genotyped. The numbers of dead fetuses are indicated in square brackets. Note the significant decrease in the number of live myocardial *Smad4* conditional knockout embryos between E13.5 and E14.5 indicates a mid-gestational lethality.
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